Also trades as: CLTN.SW (SIX) · $vol 0M · 0QP7.L (LSE) · $vol 0M

$61.16

+0.00 (+0.00%)

OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 48 · $365.5M mcap · 3M float · 0.0001% daily turnover

Revenue

$240M -4.0% ▼

5Y CAGR: -0.7%

Gross Profit

$149M -5.0% ▼

5Y CAGR: -0.3%

Operating Income

$21M -21.7% ▼

5Y CAGR: -2.0%

Net Income

$15M -27.0% ▼

5Y CAGR: +12.7%

EPS (Diluted)

$2.49 -27.2% ▼

5Y CAGR: +12.5%

EBITDA

$26M -23.5% ▼

5Y CAGR: -0.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$279M	$267M	$243M	$250M	$240M
YoY Growth	+12.4%	-4.3%	-9.1%	+3.1%	-4.0%
Cost of Revenue	$102M	$99M	$87M	$93M	$91M
Gross Profit	$177M	$168M	$156M	$157M	$149M
Gross Margin	63.4%	63.0%	64.2%	62.7%	62.1%
R&D Expenses	$9M	$9M	$10M	$0	$0
SG&A Expenses	$102M	$102M	$31M	$32M	$33M
Operating Expenses	$133M	$134M	$136M	$130M	$128M
Operating Income	$44M	$35M	$20M	$27M	$21M
Operating Margin	15.7%	13.1%	8.1%	10.7%	8.8%
Interest Expense	$415K	$232K	$837K	$854K	$511K
Income Before Tax	$41M	$33M	$16M	$26M	$18M
Tax Expense	$9M	$7M	$4M	$6M	$4M
Net Income	$32M	$26M	$12M	$20M	$15M
Net Margin	11.4%	9.7%	4.9%	8.2%	6.2%
EPS (Diluted)	$5.31	$4.35	$2.00	$3.42	$2.49
EBITDA	$47M	$40M	$24M	$34M	$26M
Shares Outstanding	6M	6M	6M	6M	6M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$132M	$131M	$111M	$128M	$123M	$118M	$122M	$113M
Cost of Revenue	$93M	$96M	$87M	$43M	$89M	$40M	$51M	$40M
Gross Profit	$39M	$36M	$24M	$85M	$33M	$78M	$71M	$73M
Gross Margin	29.8%	27.1%	21.6%	66.6%	27.1%	66.4%	58.0%	65.0%
R&D Expenses	$9M	$0	$10M	$0	$0	$0	$0	$0
SG&A Expenses	$21M	$21M	$10M	$47M	$19M	$46M	-$13M	$43M
Operating Expenses	$21M	$21M	$19M	$72M	$58M	$71M	$57M	$68M
Operating Income	$18M	$14M	$5M	$13M	$14M	$8M	$13M	$6M
Operating Margin	13.8%	11.0%	4.7%	10.2%	11.3%	6.4%	11.0%	5.1%
Interest Expense	$845K	$1M	-$327K	$0	$903K	$2M	-$1M	$0
Income Before Tax	$17M	$13M	$3M	$14M	$13M	$6M	$13M	$5M
Tax Expense	$4M	$3M	$931K	$3M	$3M	$1M	$2M	$1M
Net Income	$14M	$10M	$2M	$10M	$10M	$4M	$11M	$4M
Net Margin	10.5%	7.6%	1.7%	8.2%	8.2%	3.6%	8.8%	3.6%
EPS (Diluted)	$2.32	$1.68	$0.32	$1.74	$1.68	$0.71	$1.78	$0.68
EBITDA	$22M	$18M	$9M	$17M	$17M	$11M	$15M	$9M
Shares Outstanding	6M	6M	6M	6M	6M	6M	6M	6M

CLHLF OTC